Avadel pharmaceuticals expands leadership team with three strategic hires

Bolsters team with addition of established biopharma industry leaders in advance of anticipated regulatory approval and commercialization of once-nightly ft218 for narcolepsy bolsters team with addition of established biopharma industry leaders in advance of anticipated regulatory approval and commercialization of once-nightly ft218 for narcolepsy
AVDL Ratings Summary
AVDL Quant Ranking